Science and Research

International documentation on the use of Cytotect CP® Biotest for patients after lung and heart transplantation

Prospective documentation of the real-world usage of Cytotect for prophylaxis, pre-emptive treatment and treatment of CMV infection after heart transplantation (HT) and lung transplantation (LT).

Study details
DZL Disease Area: ROR
DZL Disease Area: ROR
Study Type: Observational
Study Type: Observational
DZL Role: DZL recruiting center
DZL Role: DZL recruiting center
Funding: Externally - industry
Funding: Externally - industry
DZL Participating Sites: BREATH
DZL Participating Sites: BREATH
Start Date: 28.12.2022
Completion Date: 01.12.2027
Status: Recruiting
Status: Recruiting
DZL recruiting center


close
chevron-down

Unsere Seite verwendet Cookies und ähnliche Technologien. Mit der Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Mehr Informationen dazu finden Sie in unserer Datenschutzerklärung.